HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way

Author:

Wu Xianjian1,Xu Zuoming1,Li Wenchuan1,Lu Yuan1,Pu Jian1

Affiliation:

1. Department of Hepatobiliary Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi 533000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Reference56 articles.

1. Prevention of hepatocellular carcinoma and its recurrence with anti-hepatitis B viral therapy;Halegoua-De Marzio;Minerva Gastroenterol Dietol,2014

2. Experimental drug treatments for hepatocellular carcinoma: Clinical trial failures 2015 to 2021;Brown;Expert Opin Investig Drugs,2022

3. Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver;Fan;Mol Med Rep,2018

4. Liver cancer cell of origin, molecular class, and effects on patient prognosis;Sia;Gastroenterology,2017

5. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide;Maucort-Boulch;Int J Cancer,2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Regulation of the HIF switch in human endothelial and cancer cells;European Journal of Cell Biology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3